| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82576 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
125 |
axc |
2024-12-20 |
| 82577 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
121 |
zyl |
2024-12-20 |
| 82578 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
132 |
kx |
2024-12-20 |
| 82579 |
Tos-PEG3-CH2COOtBu |
139 |
h |
2024-12-20 |
| 82580 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
179 |
axc |
2024-12-20 |
| 82581 |
HO-PEG7-CH2COOH |
177 |
h |
2024-12-20 |
| 82582 |
Mc-vc-PABC-SP 141 -ADC连接子 |
145 |
zyl |
2024-12-20 |
| 82583 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
165 |
WYQ |
2024-12-20 |
| 82584 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
118 |
kx |
2024-12-20 |
| 82585 |
Amino-PEG12-CH2COOH |
114 |
h |
2024-12-20 |
| 82586 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
113 |
WYQ |
2024-12-20 |
| 82587 |
HO-PEG12-CH2COOH |
112 |
h |
2024-12-20 |
| 82588 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
119 |
kx |
2024-12-20 |
| 82589 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
219 |
axc |
2024-12-20 |
| 82590 |
Amino-PEG3-CH2COOH |
124 |
h |
2024-12-20 |
| 82591 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
192 |
WYQ |
2024-12-20 |
| 82592 |
Tos-PEG4-CH2COOH |
139 |
h |
2024-12-20 |
| 82593 |
cas:663598-85-4,N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate, ADC试剂 |
100 |
kx |
2024-12-20 |
| 82594 |
负载姜黄素的胆碱修饰的脂质体,NP1/Cur,定制服务 |
140 |
axc |
2024-12-20 |
| 82595 |
Boc-NH-PEG4-CH2COOH |
95 |
h |
2024-12-20 |
| 82596 |
CAS: 1951424-92-2,Fmoc-Ala-Ala-Asn(Trt)-OH |
137 |
WYQ |
2024-12-20 |
| 82597 |
CAS:1618096-56-2 Mc-Dexamethasone 抗体-药物偶联物(ADC) |
147 |
zyl |
2024-12-20 |
| 82598 |
CAS: 1639939-40-4,MC-Val-Ala-PAB-PNP |
180 |
WYQ |
2024-12-20 |
| 82599 |
Fmoc-NH-PEG4-CH2COOH |
112 |
h |
2024-12-20 |
| 82600 |
perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate,ADC定制 |
120 |
kx |
2024-12-20 |
| 82601 |
CAS: 1870916-87-2,MC-Val-Ala-PAB,6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-N-((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁-2-基)己酰胺 |
110 |
WYQ |
2024-12-20 |
| 82602 |
Amino-PEG4-CH2COOH |
132 |
h |
2024-12-20 |
| 82603 |
CAS号1473403-87-0 MC-SN38 抗体-药物偶联物(ADC) |
181 |
zyl |
2024-12-20 |
| 82604 |
Alkyne-Val-Cit-PAB-PNP(CAS号:2748039-77-0) |
118 |
WYQ |
2024-12-20 |
| 82605 |
Fmoc-NH-PEG4-CH2CH2COOH |
152 |
h |
2024-12-20 |
| 82606 |
cas:1007215-94-2,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate |
115 |
kx |
2024-12-20 |
| 82607 |
HS-PEG5-CH2CH2NH2 hydrochloride |
151 |
h |
2024-12-20 |
| 82608 |
Thiol-PEG5-amine |
106 |
h |
2024-12-20 |
| 82609 |
SGD-1910 (Mc-Val-Ala-PBD ) cas:1342820-51-2 |
128 |
zyl |
2024-12-20 |
| 82610 |
Alkyne-Val-Cit-PAB-FAM(CAS号:2748039-76-9 |
199 |
WYQ |
2024-12-20 |
| 82611 |
cas:60444-78-2,2,5-Dioxopyrrolidin-1-yl 4-formylbenzoate, 4-甲酰苯甲酸N-琥珀酰亚胺酯,抗体药物偶联物(ADC) |
120 |
kx |
2024-12-20 |
| 82612 |
HO-PEG8-CH2CH2COOH |
181 |
h |
2024-12-20 |
| 82613 |
Fmoc-Val-Ala-PAB-PNP(CAS号:1394238-92-6) |
163 |
WYQ |
2024-12-20 |
| 82614 |
Thiol-PEG7-propionic acid |
173 |
h |
2024-12-20 |
| 82615 |
Boc-NH-PEG11-CH2CH2N3 |
115 |
h |
2024-12-20 |
| 82616 |
cas:478801-48-8,5-azidopentanoic acid N-hydroxysuccinimide ester, ADC试剂 |
136 |
kx |
2024-12-20 |
| 82617 |
MC-Val-Cit-PAB-OH CAS编号:159857-80-4 |
159 |
WYQ |
2024-12-20 |
| 82618 |
MA-PEG4-vc-PAB-DMEA-duocarmycin SA一种用于开发抗体-药物偶联物的 DNA 修饰剂 |
253 |
zyl |
2024-12-20 |
| 82619 |
CAS: 175724-30-8,Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane |
152 |
WYQ |
2024-12-20 |
| 82620 |
Boc-NH-PEG10-CH2CH2NH2 |
118 |
h |
2024-12-20 |